Han N - Search Results

1

Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases.

Jin K, Li G, Cui B, Zhang J, Lan H, Han N, Xie B, Cao F, He K, Wang H, Xu Z, Teng L, Zhu T. Jin K, et al. Among authors: han n. PLoS One. 2011;6(12):e28384. doi: 10.1371/journal.pone.0028384. Epub 2011 Dec 2. PLoS One. 2011. PMID: 22164281 Free PMC article.

2

FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo.

Jin K, He K, Teng F, Li G, Wang H, Han N, Xu Z, Cao J, Wu J, Yu D, Teng L. Jin K, et al. Among authors: han n. Clin Transl Oncol. 2011 Dec;13(12):878-84. doi: 10.1007/s12094-011-0749-z. Clin Transl Oncol. 2011. PMID: 22126731

3

Establishment of a PDTT xenograft model of gastric carcinoma and its application in personalized therapeutic regimen selection.

Jin K, He K, Han N, Li G, Wang H, Xu Z, Jiang H, Zhang J, Teng L. Jin K, et al. Among authors: han n. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1814-22. doi: 10.5754/hge11136. Epub 2011 Jul 15. Hepatogastroenterology. 2011. PMID: 21940303

4

Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.

Dong X, Jin K, Hu X, Du F, Lan H, Han N, Ma Z, Xie B, Cui B, Teng L, Cao F. Dong X, et al. Among authors: han n. Int J Mol Med. 2012 Jul;30(1):126-32. doi: 10.3892/ijmm.2012.968. Epub 2012 Apr 10. Int J Mol Med. 2012. PMID: 22505231

5

FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.

Gao W, Jin K, Lan H, Han N, Cao F, Teng L. Gao W, et al. Among authors: han n. Hepatogastroenterology. 2012 Nov-Dec;59(120):2543-7. doi: 10.5754/hge12159. Hepatogastroenterology. 2012. PMID: 22534543

6

Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases.

Jin K, Lan H, Cao F, Han N, Xu Z, Li G, He K, Teng L. Jin K, et al. Among authors: han n. Int J Oncol. 2012 Aug;41(2):583-8. doi: 10.3892/ijo.2012.1469. Epub 2012 May 10. Int J Oncol. 2012. PMID: 22581265

7

Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.

Jin K, Lan H, Xie B, He K, Xu Z, Li G, Han N, Teng L, Cao F. Jin K, et al. Among authors: han n. Cancer Biol Ther. 2012 Jul;13(9):737-44. doi: 10.4161/cbt.20556. Epub 2012 May 23. Cancer Biol Ther. 2012. PMID: 22617773 Free article.

8

Antitumor effect of FP3 in a patient-derived tumor tissue xenograft model of gastric carcinoma through an antiangiogenic mechanism.

Jin K, Lan H, Cao F, Xu Z, Han N, Li G, He K, Teng L. Jin K, et al. Among authors: han n. Oncol Lett. 2012 May;3(5):1052-1058. doi: 10.3892/ol.2012.603. Epub 2012 Feb 10. Oncol Lett. 2012. PMID: 22783390 Free PMC article.

9

Heterogeneity between primary colon carcinoma and paired lymphatic and hepatic metastases.

Lan H, Jin K, Xie B, Han N, Cui B, Cao F, Teng L. Lan H, et al. Among authors: han n. Mol Med Rep. 2012 Nov;6(5):1057-68. doi: 10.3892/mmr.2012.1051. Epub 2012 Aug 28. Mol Med Rep. 2012. PMID: 22940867

10

Radiofrequency ablation, heat shock protein 70 and potential anti-tumor immunity in hepatic and pancreatic cancers: a minireview.

Teng LS, Jin KT, Han N, Cao J. Teng LS, et al. Among authors: han n. Hepatobiliary Pancreat Dis Int. 2010 Aug;9(4):361-5. Hepatobiliary Pancreat Dis Int. 2010. PMID: 20688598 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,362 results

Search Page

Filters